Jade Williams, Author at European Medical Journal - Page 11 of 22

The price is wrong

The pandemic has exacerbated already troubling trends in the market access but has also created an opportunity for change in how drugs are priced and procured.

Examining pharma's role in protecting the planet

Pharma is making great strides in tackling climate change, but more needs to be done to meet net zero targets.

Davidek Herron on the future of pharma

In his second column, Davidek Herron, Global Head of Digital, Roche, considers this year’s successes and challenges and looks ahead to 2023.

Is the pharma rep at death's door?

While technology advances and mindsets shift, will there be space and demand for the role of the pharma sales reps in future?

Pharma in Japan

The Japanese pharma industry has many intricacies, so how can companies navigate the ups and downs?

Pharma's sustainability agenda centre stage in new ABPI report

Global action is required to ensure pharma’s commitments to reach Net Zero are realised, according to a new ABPI report.

Daiichi Sankyo's Mary Pinder-Schenck on oncology innovation

Daiichi Sankyo’s Mary Pinder-Schenck speaks about the evolution she has witnessed in oncology throughout her career and what she predicts for the future of the field.

Could the UK become a medicinal cannabis leader?

A new review has outlined 20 recommendations for how the UK can become a world leader in cannabinoid innovation. But is it possible?

Pfizer joins GSK in RSV success

Pfizer plans to file for approval for its RSV vaccine for infants by the end of 2022 after achieving positive Phase 3 results.

How is pharma improving animal testing – and what do activists think?

The pharmaceutical industry has been trying to refine, reduce and replace animal testing for some time, but animal rights activists argue progress is too incremental.